SCHEMBL1707844

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL2898209	0.87	MYC (0.54)	TSHRLMNAMAPTMEN1HTT
	SCHEMBL4304084	0.85	TSHR (0.51)	CYP3A4TSHRMAPTMEN1MAPK10
	SCHEMBL12640975	0.84	CA12 (0.49)	CYP3A4ACHETSHRLMNAMAPT
	SCHEMBL19849652	0.82	TSHR (0.53)	TSHRLMNAMAPTMEN1HTT
	SCHEMBL29634134	0.82	TSHR (0.53)	TSHRLMNAMAPTMEN1HTT
	SCHEMBL562649	0.81	CHEK1 (0.44)	TSHRLMNAMAPTMEN1HTT
	SCHEMBL17385781	0.79	MAPT (0.40)	CYP3A4ACHETSHRLMNAMAPT
	SCHEMBL17386114	0.78	SLC22A6 (0.41)	CYP3A4ACHETSHRLMNAMAPT
	SCHEMBL2907419	0.78	REN (0.47)	TSHRMAPTMEN1HTTMAPK10
	SCHEMBL2911775	0.78	PDCD1 (0.38)	TSHRLMNAMAPTMEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.